Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Determining the Competence of the Immune System Over the First Year of Therapy in Patients With Glioma: A Battery of Quantitative, Qualitative and Functional Measures of Immune Readiness

Trial Profile

Determining the Competence of the Immune System Over the First Year of Therapy in Patients With Glioma: A Battery of Quantitative, Qualitative and Functional Measures of Immune Readiness

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 01 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Hepatitis A vaccine inactivated (Primary) ; Influenza virus vaccine (Agriflu) (Primary) ; Tetanus vaccine (Primary) ; Hepatitis B vaccine; Temozolomide
  • Indications Hepatitis A; Influenza virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 28 Oct 2021 Status changed from active, no longer recruiting to completed.
    • 21 Jul 2021 Planned End Date changed from 1 Jul 2021 to 1 Oct 2021.
    • 28 Apr 2021 Planned End Date changed from 1 Apr 2021 to 1 Jul 2021.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top